This article provides a comprehensive comparative analysis for researchers and drug development professionals on two revolutionary therapeutic classes for neurological disorders: gene therapies and RNA-based treatments.
This article provides a comprehensive analysis of the reliability and performance of various automated segmentation tools when applied to contrast-enhanced magnetic resonance imaging (CE-MR) scans.
This article provides a comprehensive analysis for researchers and drug development professionals on the paradigm shift from traditional clinical endpoints to digital biomarkers.
This article explores the transformative impact of high-resolution and ultra-high-field Magnetic Resonance Imaging (MRI) on tissue specificity, a critical factor for researchers and drug development professionals.
This article explores the transformative role of Artificial Intelligence (AI) in modeling patient recruitment feasibility for clinical trials.
This article provides a comprehensive analysis of Multimodal Large Language Models (MLLMs) for brain MRI sequence classification, a critical task for automating medical imaging workflows.
This article provides a comprehensive analysis for researchers and drug development professionals on the paradigm shift from traditional randomized control trials (RCTs) to synthetic control arms (SCAs) in neuroscience.
This article provides a comprehensive analysis of contrast-enhanced (CE) and non-contrast (NC) MRI for brain volumetry, a critical biomarker in neurodegenerative disease research and clinical trials.
Automated perfusion analysis software has become pivotal for extending treatment windows in acute ischemic stroke, guiding life-saving decisions for endovascular therapy.
This article provides a comprehensive analysis of the comparative performance between the established RAPID software and the newly developed JLK PWI platform for automated ischemic core and penumbra estimation using...